Back to Search Start Over

Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials

Authors :
Qianqian Xin
Qianhui Wu
Xinhua Chen
Bihua Han
Kai Chu
Yan Song
Hui Jin
Panpan Chen
Wanying Lu
Tuantuan Yang
Minjie Li
Yuliang Zhao
Hongxing Pan
Hongjie Yu
Lin Wang
Source :
Nature Communications, Vol 13, Iss 1, Pp 1-7 (2022)
Publication Year :
2022
Publisher :
Nature Portfolio, 2022.

Abstract

Following a booster dose of CoronaVac in two single-centre phase 2 clinical trials, the authors show that neutralising antibody titres decline approximately 4-fold and 2.5-fold from day 28 to day 180 in adults aged 18-59 years and in adults aged 60 years and older, respectively.

Subjects

Subjects :
Science

Details

Language :
English
ISSN :
20411723
Volume :
13
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Nature Communications
Publication Type :
Academic Journal
Accession number :
edsdoj.642522102d4744c7beaea9ab544b6cbd
Document Type :
article
Full Text :
https://doi.org/10.1038/s41467-022-30864-w